Outlook Therapeutics, Inc. 8-K

What Happened
Outlook Therapeutics, Inc. (OTLK) announced its financial results for the second fiscal quarter ended March 31, 2026, via a press release dated May 15, 2026. The company furnished that press release as Exhibit 99.1 to a Current Report on Form 8-K filed on May 18, 2026 under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Reporting item: Item 2.02 — Results of Operations and Financial Condition.
• Quarter covered: second fiscal quarter ended March 31, 2026.
• Press release date: May 15, 2026; furnished as Exhibit 99.1 to the Form 8-K filed May 18, 2026.
• The Form 8-K includes the press release (Exhibit 99.1) and the Inline XBRL cover page (Exhibit 104).

Why It Matters
Quarterly results provide updated information on Outlook Therapeutics’ recent earnings, revenue, cash position and operating performance — key metrics investors use to assess near-term prospects. The furnished press release is the company’s official disclosure of those results; investors should read it (and the company’s subsequent filings) for the specific figures, any management commentary, and any updated outlook or guidance.